Proton Pump Inhibitors Effects on Dyspepsia During Ramadan Fasting

Last updated: February 23, 2025
Sponsor: University of Monastir
Overall Status: Completed

Phase

1/2

Condition

Heartburn (Pediatric)

Heartburn

Colic

Treatment

Esomeprazole

Placebo

Clinical Study ID

NCT05287633
PPI
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

evaluate the interest of proton pump inhibitors in subjects with or with GI symptoms who intend to observe fasting in Ramadan. The investigators will compare the effectiveness of proton pump inhibitors to prevent or reduce the signs of dyspepsia during Ramadan compared to placebo.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Exclusion

  • Exclusion Criteria:

  • Diagnosed GastroDuodenal Ulcer

Study Design

Total Participants: 500
Treatment Group(s): 2
Primary Treatment: Esomeprazole
Phase: 1/2
Study Start date:
January 20, 2020
Estimated Completion Date:
December 30, 2024

Study Description

evaluate the interest of proton pump inhibitors in subjects with or with GI symptoms who intend to observe fasting in Ramadan. Investigators will compare the effectiveness of proton pump inhibitors to prevent or reduce the signs of dyspepsia during at least Ramadan compared to placebo.

The study will be conducted at least from April 2019 to at least June 2030.The study is prospective, two parallel groups, randomized controlled and double blind.

Connect with a study center

  • Emergency department of university hospital Fattouma Bourguiba of Monastir Monastir, Monastir Tunisia

    Monastir, 5000
    Tunisia

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.